Wednesday, September 25, 2019
- 1:15pm-2:45pm
-
Antibiotic exposure and Risk for Parkinson’s Disease
Epidemiology · Les Muses, Level 3
- 1:15pm-2:45pm
-
Antipsychotics Use in Parkinson’s Disease and Mortality Risks
Epidemiology · Les Muses, Level 3
- 1:15pm-2:45pm
-
Anxiety and dopaminergic stimulation in patients with Parkinson´s disease.
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Apathy and cognitive profile in Parkinson´s disease: A cross-sectional study in Cali-Colombia
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Appendectomy and risk of Parkinson’s disease: A meta-analysis using real-world evidence
Surgical Therapy · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Applicability of questionnaires and study of the prevalence of REM Sleep Behavior Disorder (RBD) in Parkinson’s disease
Non-Motor Symptoms · Agora 3 West, Level 3
- 1:15pm-2:45pm
-
Applicability of short form of Montreal Cognitive Assessment to Brazilian Portuguese
Cognition and Cognitive Disorders · Agora 3 East, Level 3
- 1:15pm-2:45pm
-
Appropriateness of DAT Scan Ordering in a University Hospital Practice
Neuroimaging · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Apraxia of Eye Lid Opening in patients with advanced Parkinson’s disease undergoing subthalamic stimulation – a single-centre experience.
Surgical Therapy · Les Muses Terrace, Level 3
- 1:15pm-2:45pm
-
Are there associations between altered brain connectivity and dopaminergic medication in Parkinson’s disease patients with freezing of gait?
Neuroimaging · Les Muses Terrace, Level 3
- «Previous Page
- 1
- …
- 3
- 4
- 5
- 6
- 7
- …
- 67
- Next Page»